secwatch / observer
8-K filed February 10, 2023, 6:59 PM ET ticker OCEA CIK 0001869974
M&A confidence high sentiment positive materiality 0.75

Aesther enters $60M backstop agreement with Vellar to support Ocean Biomedical merger

Ocean Biomedical, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Ocean Biomedical, Inc. amended Backstop Agreement with Vellar Opportunity Fund SPV LLC – Series 3 valued at Vellar agrees to purchase up to 6,000,000 shares for up to $60,000,000; Aesther purchases on forward (effective 2023-02-10).

Action
amendment
Agreement
equity purchase
Counterparty
Vellar Opportunity Fund SPV LLC – Series 3
Value
Vellar agrees to purchase up to 6,000,000 shares for up to $60,000,000; Aesther purchases on forward
Effective
2023-02-10
Exact text from the filing
Pursuant to the Backstop Agreement, Vellar has agreed to support the Transaction by purchasing up to 6,000,000 shares of Aesther Class A common stock in the open market for up to $60,000,000, including from other Aesther stockholders that elected to redeem and subsequently revoked their prior elections to redeem their shares, following the expiration of the Company’s redemption offer. Aesther has agreed to purchase those shares from Vellar on a forward basis. The purchase price payable by the Company will include a prepayment in the amount of the redemption price per share.
View on SEC.gov

Browse all material agreements →

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-004252
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.